Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Rutkowski

Showing results (161-170 of 491) with videos related to

Pageof 50
Sort By:
Cancers|April 3, 2021
The Feasibility Study of Hypofractionated Radiotherapy with Regional Hyperthermia in Soft Tissue SarcomasMateusz Jacek Spałek, Aneta Maria Borkowska, Maria Telejko, et al.
Journal of Clinical Medicine|October 2, 2020
Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors-A Sarcoma Reference Center ExperiencePaweł Sobczuk, Paweł Teterycz, Anna M Czarnecka, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
The megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of boneWlodzimierz Ruka, Piotr Rutkowski, Tadeusz Morysiński, et al.
Cancer Nursing|May 26, 2005
Quality-of-life evaluation in an interferon therapy after radical surgery in cutaneous melanoma patientsDorota Rataj, Barbara Jankowiak, Elzbieta Krajewska-Kułak, et al.
Annals of Agricultural and Environmental Medicine : AAEM|December 23, 2014
Effect of isopropyl methylphosphonofluoridate (IMPF) poisoning on selected immunological parameters of angiogenesisRobert Zdanowski, Małgorzata Krzyżowska, Sławomir Lewicki, et al.
Targeted Oncology|November 23, 2019
Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine PracticeAnna M Czarnecka, Paweł Teterycz, Anna Mariuk-Jarema, et al.
Cancers|July 24, 2021
Characterization and Clinical Utility of <i>BRAF</i><sup>V600</sup> Mutation Detection Using Cell-Free DNA in Patients with Advanced MelanomaPiotr Rutkowski, Patrick Pauwels, Joseph Kerger, et al.
International Journal of Dermatology|December 22, 2010
Cutaneous melanoma with nodal metastases in elderly peoplePiotr Rutkowski, Zbigniew I Nowecki, Marcin Zdzienicki, et al.
Cancers|February 15, 2022
The Use of ctDNA for <i>BRAF</i> Mutation Testing in Routine Clinical Practice in Patients with Advanced MelanomaPaweł Sobczuk, Katarzyna Kozak, Sylwia Kopeć, et al.
Contemporary Oncology (Poznan, Poland)|June 22, 2013
Results of systemic treatment of cutaneous melanoma in inoperable stage III and IVBożena Cybulska-Stopa, Marta Skoczek, Marek Ziobro, et al.
Pageof 50

Showing results (161-170 of 491) with videos related to

Sort By:
Pageof 50
Cancers|April 3, 2021
The Feasibility Study of Hypofractionated Radiotherapy with Regional Hyperthermia in Soft Tissue SarcomasMateusz Jacek Spałek, Aneta Maria Borkowska, Maria Telejko, et al.
Journal of Clinical Medicine|October 2, 2020
Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors-A Sarcoma Reference Center ExperiencePaweł Sobczuk, Paweł Teterycz, Anna M Czarnecka, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
The megavoltage radiation therapy in treatment of patients with advanced or difficult giant cell tumors of boneWlodzimierz Ruka, Piotr Rutkowski, Tadeusz Morysiński, et al.
Cancer Nursing|May 26, 2005
Quality-of-life evaluation in an interferon therapy after radical surgery in cutaneous melanoma patientsDorota Rataj, Barbara Jankowiak, Elzbieta Krajewska-Kułak, et al.
Annals of Agricultural and Environmental Medicine : AAEM|December 23, 2014
Effect of isopropyl methylphosphonofluoridate (IMPF) poisoning on selected immunological parameters of angiogenesisRobert Zdanowski, Małgorzata Krzyżowska, Sławomir Lewicki, et al.
Targeted Oncology|November 23, 2019
Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine PracticeAnna M Czarnecka, Paweł Teterycz, Anna Mariuk-Jarema, et al.
Cancers|July 24, 2021
Characterization and Clinical Utility of <i>BRAF</i><sup>V600</sup> Mutation Detection Using Cell-Free DNA in Patients with Advanced MelanomaPiotr Rutkowski, Patrick Pauwels, Joseph Kerger, et al.
International Journal of Dermatology|December 22, 2010
Cutaneous melanoma with nodal metastases in elderly peoplePiotr Rutkowski, Zbigniew I Nowecki, Marcin Zdzienicki, et al.
Cancers|February 15, 2022
The Use of ctDNA for <i>BRAF</i> Mutation Testing in Routine Clinical Practice in Patients with Advanced MelanomaPaweł Sobczuk, Katarzyna Kozak, Sylwia Kopeć, et al.
Contemporary Oncology (Poznan, Poland)|June 22, 2013
Results of systemic treatment of cutaneous melanoma in inoperable stage III and IVBożena Cybulska-Stopa, Marta Skoczek, Marek Ziobro, et al.
Pageof 50